Seasoned biopharmaceutical executive and entrepreneur. Psychedelics, Entheogens, Psilocybin, Ibogaine, MDMA, Ketamine, Biosimilars, Recombinant Monoclonal Antibodies, Cytotoxic Drug Conjugates cGMP Cell Culture, Microbial, Cell Therapy, Technology licensing, Clinical Development, Commercialization
Founder & CEO at Ninnion Therapeutics
BS, Biological Sciences